id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-D-0124-0006,FDA,FDA-2004-D-0124,"Saline, Silicone Gel, and Alternative Breast Implants  Guidance for Industry and FDA Staff",Other,Guidance,2020-10-01T04:00:00Z,2020,10,2020-10-01T04:00:00Z,,2024-11-12T23:19:34Z,,1,0,090000648457a822
FDA-2004-D-0124-0005,FDA,FDA-2004-D-0124,Guidance,Supporting & Related Material,GDL-Guidance,2006-11-21T05:00:00Z,2006,11,,,2008-04-12T00:34:43Z,,0,0,090000648046fc8c
FDA-2004-D-0124-0004,FDA,FDA-2004-D-0124,FDA,Notice,NAD-Notice of Availability of Data,2006-11-21T05:00:00Z,2006,11,2006-11-17T05:00:00Z,2007-11-20T04:59:59Z,2008-04-12T00:34:43Z,,0,0,090000648046fc8b
FDA-2004-D-0124-0003,FDA,FDA-2004-D-0124,Guidance,Supporting & Related Material,GDL-Guidance,2004-01-13T05:00:00Z,2004,1,,,2008-04-12T00:34:43Z,,0,0,090000648046fc25
FDA-2004-D-0124-0002,FDA,FDA-2004-D-0124,Guidance,Supporting & Related Material,GDL-Guidance,2004-01-13T05:00:00Z,2004,1,,,2008-04-12T00:34:44Z,,0,0,090000648046fc24
FDA-2004-D-0124-0001,FDA,FDA-2004-D-0124,FDA,Notice,NAD-Notice of Availability of Data,2004-01-13T05:00:00Z,2004,1,2004-01-13T05:00:00Z,2004-04-13T03:59:59Z,2008-04-12T00:34:43Z,,0,0,090000648046fc18